Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000223431 | SCV000112499 | likely benign | not specified | 2015-04-11 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000223431 | SCV000270128 | likely benign | not specified | 2015-10-22 | criteria provided, single submitter | clinical testing | p.Arg1324Cys in exon 29 of DMD: This variant is not expected to have clinical si gnificance because it has been identified in 0.8% (64/8493) of African chromosom es by the Exome Aggregation Consortium, including 8 hemizygous individuals (ExAC , http://exac.broadinstitute.org; rs143184877). |
Ambry Genetics | RCV000250502 | SCV000320674 | benign | Cardiovascular phenotype | 2018-06-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000223431 | SCV000526588 | benign | not specified | 2017-01-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000990674 | SCV000560868 | benign | Duchenne muscular dystrophy | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000223431 | SCV000613119 | benign | not specified | 2017-03-31 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000853041 | SCV000995798 | likely benign | Cardiomyopathy | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990674 | SCV001141696 | likely benign | Duchenne muscular dystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000223431 | SCV001433475 | likely benign | not specified | 2020-01-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001528811 | SCV001477528 | likely benign | not provided | 2020-08-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000223431 | SCV002103718 | likely benign | not specified | 2022-02-18 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001528811 | SCV001741197 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000223431 | SCV001970312 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826748 | SCV002085382 | benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-08-02 | no assertion criteria provided | clinical testing |